Search Results - "MACHLENKIN, A"

Messenger RNA encoding constitutively active Toll‐like receptor 4 enhances effector functions of human T cells by Pato, A., Eisenberg, G., Machlenkin, A., Margalit, A., Cafri, G., Frankenburg, S., Merims, S., Peretz, T., Lotem, M., Gross, G.

“…Summary Adoptive T cell therapy of cancer employs a large number of ex‐vivo‐propagated T cells which recognize their targets either by virtue of their…”
Get full text

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides by BAR-HAIM, E, PAZ, A, LEMONNIER, F. A, TZEHOVAL, E, EISENBACH, L, MACHLENKIN, A, HAZZAN, D, TIROSH, B, CARMON, L, BRENNER, B, VADAI, E, MOR, O, STEIN, A

“…Bladder carcinoma is the fourth most common cancer in men and the eighth most common cancer among women. Our study is aimed to characterise tumour-associated…”
Get full text

'1-8 interferon inducible gene family' : putative colon carcinoma-associated antigens by TIROSH, B, DANIEL-CARMI, V, FRIDKIN, M, TZEHOVAL, E, EISENBACH, L, CARMON, L, PAZ, A, LUGASSY, G, VADAI, E, MACHLENKIN, A, BAR-HAIM, E, DO, M-S, AHN, I. S

Get full text

Combined Dendritic Cell Cryotherapy of Tumor Induces Systemic Antimetastatic Immunity by MACHLENKIN, Arthur, GOLDBERGER, Ofir, TIROSH, Boaz, PAZ, Adrian, VOLOVITZ, Ilan, BAR-HAIM, Erez, LEE, Sung-Hyung, VADAI, Ezra, TZEHOVAL, Esther, EISENBACH, Lea

“…Purpose: Cryotherapy of localized prostate, renal, and hepatic primary tumors and metastases is considered a minimally invasive treatment demonstrating a low…”
Get full text

HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccine by Lotem, M., Kadouri, L., Merims, S., Ospovat, I., Nissan, A., Ron, I., Frankenburg, S., Machlenkin, A., Israel, S., Steinberg, H., Hamburger, T., Peretz, T.

“…This work presents survival data of 42 melanoma patients at high risk for disease recurrence who received an allogeneic melanoma vaccine composed of three cell…”
Get full text

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy by MACHLENKIN, Arthur, PAZ, Adrian, LEMONNIER, Francois, TZEHOVAL, Esther, EISENBACH, Lea, HAIM, Erez Bar, GOLDBERGER, Ofir, FINKEL, Eran, TIROSH, Boaz, VOLOVITZ, Ilan, VADAI, Ezra, LUGASSY, Gilles, CYTRON, Shmuel

“…Specific immunotherapy of prostate cancer may be an alternative or be complementary to other approaches for treatment of recurrent or metastasized disease…”
Get full text

1,25-dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage by RAVID, A, ROCKER, D, MACHLENKIN, A, ROTEM, C, HOCHMAN, A, KESSLER-ICEKSON, G, LIBERMAN, U. A, KOREN, R

“…1,25-Dihydroxyvitamin D3 (1,25(OH)2D3), the hormonal form of vitamin D, has anticancer activity in vivo and in vitro. Doxorubicin exerts its cytotoxic effect…”
Get full text

'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens by Tirosh, B, Daniel-Carmi, V, Carmon, L, Paz, A, Lugassy, G, Vadai, E, Machlenkin, A, Bar-Haim, E, Do, M-S, Ahn, I S, Fridkin, M, Tzehoval, E, Eisenbach, L

“…D(b-/-)xbeta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/D(b)-beta2m single chain (HHD mice) are an effective biological tool to…”
Get full text

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL by Lee, Sung-Hyung, Bar-Haim, Erez, Machlenkin, Arthur, Goldberger, Ofir, Volovitz, Ilan, Vadai, Ezra, Tzehoval, Esther, Eisenbach, Lea

“…Perforin/granzyme B- and Fas/FasL-mediated killing pathways are the main effector mechanisms of CTL and NK cells in antitumor immune responses. In this study,…”
Get full text

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL by Volovitz, Ilan, Eisenbach, Lea, Goldberger, Ofir, Lee, Sung-Hyung, Machlenkin, Arthur, Bar-Haim, Erez, Vadai, Ezra, Tzehoval, Esther

Get full text

1,25-Dihydroxyvitamin D sub(3) Enhances the Susceptibility of Breast Cancer Cells to Doxorubicin-induced Oxidative Damage by Ravid, A, Rocker, D, Machlenkin, A, Rotem, C, Hochman, A, Kessler-Icekson, G, Liberman, U A, Koren, R

“…1,25-Dihydroxyvitamin D sub(3) (1,25(OH) sub(2)D sub(3)), the hormonal form of vitamin D, has anticancer activity in vivo and in vitro. Doxorubicin exerts its…”
Get full text